Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany

Epilepsy and Behavior

Volumn 16, Issue 3, 2009, Pages 423-425

  Wehner, Tim ^a   Bauer, Sebastian ^a   Hamer, Hajo M ^a   Hattemer, Katja ^a   Immisch, Ilka ^a   Knake, Susanne ^a   Nowak, Mareike ^a   Reif, Philipp S ^a   Strzelczyk, Adam ^a   Rosenow, Felix ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Add on therapy; Lacosamide; Partial epilepsy; Partial onset seizures; Pharmacoresistant; Pharmacotherapy; Weight loss

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; RUFINAMIDE; ZONISAMIDE;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CONTROLLED STUDY; COORDINATION DISORDER; DEPRESSION; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENERGY; EPILEPSY; FATIGUE; FEMALE; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; GAIT DISORDER; GERMANY; HEADACHE; HEMISPHERIC EPILEPSY; HUMAN; INSOMNIA; INSULAR EPILEPSY; IRRITABILITY; MAINTENANCE THERAPY; MALE; MEMORY DISORDER; MULTIFOCAL EPILEPSY; NAUSEA; NEUROLOGICAL COMPLICATION; PERFORMANCE; PRURITUS; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; TEMPORAL LOBE EPILEPSY; TERTIARY HEALTH CARE; TONIC CLONIC SEIZURE; TREMOR; WEIGHT REDUCTION;

ACETAMIDES; ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; COHORT STUDIES; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; VIDEO RECORDING; YOUNG ADULT;

EID: 70449533094     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.07.043     Document Type: Article

References (8)

1. Kwan P., and Brodie M. Early identification of refractory epilepsy. N Engl J Med 342 (2000) 314-319
2. Schmidt D., and Löscher W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46 (2005) 858-877
3. Perucca E., Yasothan U., Clincke G., and Kirkpatrick P. Lacosamide. Nat Drug Discov 7 (2008) 973-974
4. Ben-Menachem E., Biton V., Jatuzis D., Abou-Khalil B., Doty P., and Rudd D.G. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48 (2007) 1308-1317
5. Chung S., Sperling M., Biton V., Krauss G., Beaman M., and Hebert D. Lacosamide: efficacy and safety as oral adjunctive treatment for partial-onset seizures (SP754). Epilepsia 48 Suppl. 6 (2007) 321 [abstract]
6. Halász P., Kälviäinen R., Mazurkiewicz-Beldzińska M., et al. For the SP755 Study Group. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 50 (2009) 443-453
7. ® 2008. Available from: http://www.emea.europa.eu/humandocs/PDFs/EPAR/vimpat/H-863-PI-en.pdf.
8. Doty P, Biton V, Fountain NB, et al. Safety and tolerability of lacosamide: a summary of adverse events in epilepsy clinical trials. Poster presented at the 61st annual American Academy of Neurology Meeting, Seattle, WA, April 2009. Abstract Accessed from: www.aan.com, July 10, 2009.